SoftBank to invest $900 million in gene sequencing firm Pacific Biosciences
Tweet
Share
E-mail
FILE PHOTO: The logo of SoftBank Group Corp is displayed at SoftBank World 2017 conference in Tokyo, Japan, July 20, 2017. REUTERS/Issei Kato/File Photo GLOBAL BUSINESS WEEK AHEAD
Get inside Wall Street with StreetInsider Premium. Claim your 1-week free trial here.
(Reuters) - SoftBank Group Corp will invest $900 million in gene sequencing firm Pacific Biosciences of California Inc in its latest healthcare investment, the company said on Wednesday.
(Reporting by Dania Nadeem in Bengaluru; Editing by Shinjini Ganguli)
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Chipotle expects sales surge this quarter, builds on 17.2% first-quarter growth
- Pacific Biosciences of California, Inc. First Quarter 2021 Financial Results Call
- Blucora shareholders re-elect board, reject four Ancora nominees
Create E-mail Alert Related Categories
General News, ReutersSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
